$199.99
This course offers in-depth training on the CMS Proposed Rule introducing new standards for electronic prior authorization and data exchange for Medicare Advantage, Medicaid, CHIP, and Qualified Health Plan issuers. Learn the latest requirements for HL7 FHIR APIs, API endpoint reporting, expanded prior authorization processes for drugs, and strengthened interoperability mandates. Gain actionable insights to ensure compliance, reduce administrative burden, and improve care coordination across impacted health care payers and providers.
In this course you will learn the following:
* Understand the purpose and intent of the proposed rule.
* Identify the key provisions and affected entities.
* Recognize the importance of public participation and feedback.
* Anticipate potential changes as the rule evolves.
* Analyze the expected impacts on health care data exchange and prior authorization.
NOTE: Unless otherwise indicated, all course purchases are for access to the course for a period of 1-year. At the end of the one year term, the course will be set to “inactive”.
Why This Course is Important
Without this course, you risk falling behind on federal compliance, missing critical interoperability deadlines, and facing potential penalties for non-conformance with the latest CMS mandates.
Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; Interoperability Standards and Prior Authorization for Drugs for Medicare Advantage Organizations, Medicaid Managed Care Plans, State Medicaid Agencies, Children’s Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, and Issuers of Qualified Health Plans on the Federally-Facilitated Exchanges.
Key regulatory references include:
Course SKU
FR-26-1862-1
CourseAvenue eLearning Platform has helped Federal agencies (and their suppliers) successfully address their most complex eLearning accessibility challenges.
Federal Register Title
This benchmark will help determine your readiness for: Federal Register Document titled Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment. Document Number: 2026-11526
Buy this Course
FR-26-1987-1
Why This Course is Important
Without this course, practitioners risk non-compliance with updated DEA rules, potential loss of prescribing privileges, audit failures, and exposure to significant legal and financial penalties.
Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment.
Key regulatory references include:
Course SKU
FR-26-1987-1
© 2026 CourseAvenue, LLC | All rights reserved.
